Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uzima Bioscience appears to have been an early-stage private biotechnology company founded in 2008 and associated with San Diego, California. Publicly available information is very limited, but third-party corporate registry records identify it as Uzima Bioscience, Inc., and executive biographies for founder Gregory Stein describe it as one of his early-stage drug development companies. The available evidence indicates the company operated in the broader life science and therapeutics ecosystem, but no reliable public source clearly documents a named product pipeline, platform technology, targets, or clinical programs. The California registration is listed as inactive/forfeited, and no recent operating footprint, financing activity, or corporate website could be confirmed. As a result, Uzima Bioscience is best characterized as a defunct or inactive early-stage biotech with insufficient public disclosure to reconstruct a detailed pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uzima Bioscience.